Between 2013 and 2023, the market size value per capita for hormones in dosage except contraceptives and antibiotics in Germany exhibited a fluctuating upward trend. The value reached $58.48 in 2023, indicating a recovery from a slight decline in 2022. The year-on-year variation in 2022 and 2023 showed a modest increase of 1.81%. The compound annual growth rate (CAGR) over the last five years was approximately 1.87%, reflecting stable growth.

Future trends to watch for:

Integration of innovative hormonal therapies.
Potential regulatory changes affecting the market.
Growing public interest in personalized medicine and its impact on hormone therapies.